0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma ADMET Testing Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-7S11690
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma ADMET Testing Market Research Report 2022
BUY CHAPTERS

Global Pharma ADMET Testing Market Research Report 2025

Code: QYRE-Auto-7S11690
Report
March 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma ADMET Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharma ADMET Testing Market

Pharma ADMET Testing Market

The global market for Pharma ADMET Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma ADMET Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma ADMET Testing.
The Pharma ADMET Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma ADMET Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma ADMET Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharma ADMET Testing Market Report

Report Metric Details
Report Name Pharma ADMET Testing Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation, Merck KGaA, Agilient Technologies, Biovia (Dassault Systemes), Cyprotex Limited, Bio-Rad Laboratories, IQVIA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharma ADMET Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharma ADMET Testing Market report?

Ans: The main players in the Pharma ADMET Testing Market are CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation, Merck KGaA, Agilient Technologies, Biovia (Dassault Systemes), Cyprotex Limited, Bio-Rad Laboratories, IQVIA

What are the Application segmentation covered in the Pharma ADMET Testing Market report?

Ans: The Applications covered in the Pharma ADMET Testing Market report are Systemic Toxicity Testing, Hepatotoxicity Testing, Renal Toxicity Testing, Neurotoxicity Testing, Others

What are the Type segmentation covered in the Pharma ADMET Testing Market report?

Ans: The Types covered in the Pharma ADMET Testing Market report are In Vivo ADMET Testing, In Vitro ADMET Testing

Recommended Reports

Pharma Diagnostics

Drug Safety Testing

Clinical Testing Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma ADMET Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo ADMET Testing
1.2.3 In Vitro ADMET Testing
1.3 Market by Application
1.3.1 Global Pharma ADMET Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Systemic Toxicity Testing
1.3.3 Hepatotoxicity Testing
1.3.4 Renal Toxicity Testing
1.3.5 Neurotoxicity Testing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma ADMET Testing Market Perspective (2020-2031)
2.2 Global Pharma ADMET Testing Growth Trends by Region
2.2.1 Global Pharma ADMET Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharma ADMET Testing Historic Market Size by Region (2020-2025)
2.2.3 Pharma ADMET Testing Forecasted Market Size by Region (2026-2031)
2.3 Pharma ADMET Testing Market Dynamics
2.3.1 Pharma ADMET Testing Industry Trends
2.3.2 Pharma ADMET Testing Market Drivers
2.3.3 Pharma ADMET Testing Market Challenges
2.3.4 Pharma ADMET Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma ADMET Testing Players by Revenue
3.1.1 Global Top Pharma ADMET Testing Players by Revenue (2020-2025)
3.1.2 Global Pharma ADMET Testing Revenue Market Share by Players (2020-2025)
3.2 Global Pharma ADMET Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharma ADMET Testing Revenue
3.4 Global Pharma ADMET Testing Market Concentration Ratio
3.4.1 Global Pharma ADMET Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma ADMET Testing Revenue in 2024
3.5 Global Key Players of Pharma ADMET Testing Head office and Area Served
3.6 Global Key Players of Pharma ADMET Testing, Product and Application
3.7 Global Key Players of Pharma ADMET Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma ADMET Testing Breakdown Data by Type
4.1 Global Pharma ADMET Testing Historic Market Size by Type (2020-2025)
4.2 Global Pharma ADMET Testing Forecasted Market Size by Type (2026-2031)
5 Pharma ADMET Testing Breakdown Data by Application
5.1 Global Pharma ADMET Testing Historic Market Size by Application (2020-2025)
5.2 Global Pharma ADMET Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharma ADMET Testing Market Size (2020-2031)
6.2 North America Pharma ADMET Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharma ADMET Testing Market Size by Country (2020-2025)
6.4 North America Pharma ADMET Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma ADMET Testing Market Size (2020-2031)
7.2 Europe Pharma ADMET Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharma ADMET Testing Market Size by Country (2020-2025)
7.4 Europe Pharma ADMET Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma ADMET Testing Market Size (2020-2031)
8.2 Asia-Pacific Pharma ADMET Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharma ADMET Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharma ADMET Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma ADMET Testing Market Size (2020-2031)
9.2 Latin America Pharma ADMET Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharma ADMET Testing Market Size by Country (2020-2025)
9.4 Latin America Pharma ADMET Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma ADMET Testing Market Size (2020-2031)
10.2 Middle East & Africa Pharma ADMET Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharma ADMET Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharma ADMET Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CMIC Holdings
11.1.1 CMIC Holdings Company Details
11.1.2 CMIC Holdings Business Overview
11.1.3 CMIC Holdings Pharma ADMET Testing Introduction
11.1.4 CMIC Holdings Revenue in Pharma ADMET Testing Business (2020-2025)
11.1.5 CMIC Holdings Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Pharma ADMET Testing Introduction
11.2.4 Charles River Laboratories Revenue in Pharma ADMET Testing Business (2020-2025)
11.2.5 Charles River Laboratories Recent Development
11.3 WuXi AppTec
11.3.1 WuXi AppTec Company Details
11.3.2 WuXi AppTec Business Overview
11.3.3 WuXi AppTec Pharma ADMET Testing Introduction
11.3.4 WuXi AppTec Revenue in Pharma ADMET Testing Business (2020-2025)
11.3.5 WuXi AppTec Recent Development
11.4 Promega Corporation
11.4.1 Promega Corporation Company Details
11.4.2 Promega Corporation Business Overview
11.4.3 Promega Corporation Pharma ADMET Testing Introduction
11.4.4 Promega Corporation Revenue in Pharma ADMET Testing Business (2020-2025)
11.4.5 Promega Corporation Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Pharma ADMET Testing Introduction
11.5.4 Merck KGaA Revenue in Pharma ADMET Testing Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 Agilient Technologies
11.6.1 Agilient Technologies Company Details
11.6.2 Agilient Technologies Business Overview
11.6.3 Agilient Technologies Pharma ADMET Testing Introduction
11.6.4 Agilient Technologies Revenue in Pharma ADMET Testing Business (2020-2025)
11.6.5 Agilient Technologies Recent Development
11.7 Biovia (Dassault Systemes)
11.7.1 Biovia (Dassault Systemes) Company Details
11.7.2 Biovia (Dassault Systemes) Business Overview
11.7.3 Biovia (Dassault Systemes) Pharma ADMET Testing Introduction
11.7.4 Biovia (Dassault Systemes) Revenue in Pharma ADMET Testing Business (2020-2025)
11.7.5 Biovia (Dassault Systemes) Recent Development
11.8 Cyprotex Limited
11.8.1 Cyprotex Limited Company Details
11.8.2 Cyprotex Limited Business Overview
11.8.3 Cyprotex Limited Pharma ADMET Testing Introduction
11.8.4 Cyprotex Limited Revenue in Pharma ADMET Testing Business (2020-2025)
11.8.5 Cyprotex Limited Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Pharma ADMET Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Pharma ADMET Testing Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharma ADMET Testing Introduction
11.10.4 IQVIA Revenue in Pharma ADMET Testing Business (2020-2025)
11.10.5 IQVIA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharma ADMET Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of In Vivo ADMET Testing
 Table 3. Key Players of In Vitro ADMET Testing
 Table 4. Global Pharma ADMET Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharma ADMET Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharma ADMET Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharma ADMET Testing Market Share by Region (2020-2025)
 Table 8. Global Pharma ADMET Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharma ADMET Testing Market Share by Region (2026-2031)
 Table 10. Pharma ADMET Testing Market Trends
 Table 11. Pharma ADMET Testing Market Drivers
 Table 12. Pharma ADMET Testing Market Challenges
 Table 13. Pharma ADMET Testing Market Restraints
 Table 14. Global Pharma ADMET Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharma ADMET Testing Market Share by Players (2020-2025)
 Table 16. Global Top Pharma ADMET Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma ADMET Testing as of 2024)
 Table 17. Ranking of Global Top Pharma ADMET Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharma ADMET Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharma ADMET Testing, Headquarters and Area Served
 Table 20. Global Key Players of Pharma ADMET Testing, Product and Application
 Table 21. Global Key Players of Pharma ADMET Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharma ADMET Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharma ADMET Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharma ADMET Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharma ADMET Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharma ADMET Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharma ADMET Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharma ADMET Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharma ADMET Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharma ADMET Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharma ADMET Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharma ADMET Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharma ADMET Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharma ADMET Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharma ADMET Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharma ADMET Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharma ADMET Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharma ADMET Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharma ADMET Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharma ADMET Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharma ADMET Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharma ADMET Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharma ADMET Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharma ADMET Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. CMIC Holdings Company Details
 Table 47. CMIC Holdings Business Overview
 Table 48. CMIC Holdings Pharma ADMET Testing Product
 Table 49. CMIC Holdings Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 50. CMIC Holdings Recent Development
 Table 51. Charles River Laboratories Company Details
 Table 52. Charles River Laboratories Business Overview
 Table 53. Charles River Laboratories Pharma ADMET Testing Product
 Table 54. Charles River Laboratories Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 55. Charles River Laboratories Recent Development
 Table 56. WuXi AppTec Company Details
 Table 57. WuXi AppTec Business Overview
 Table 58. WuXi AppTec Pharma ADMET Testing Product
 Table 59. WuXi AppTec Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 60. WuXi AppTec Recent Development
 Table 61. Promega Corporation Company Details
 Table 62. Promega Corporation Business Overview
 Table 63. Promega Corporation Pharma ADMET Testing Product
 Table 64. Promega Corporation Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 65. Promega Corporation Recent Development
 Table 66. Merck KGaA Company Details
 Table 67. Merck KGaA Business Overview
 Table 68. Merck KGaA Pharma ADMET Testing Product
 Table 69. Merck KGaA Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 70. Merck KGaA Recent Development
 Table 71. Agilient Technologies Company Details
 Table 72. Agilient Technologies Business Overview
 Table 73. Agilient Technologies Pharma ADMET Testing Product
 Table 74. Agilient Technologies Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 75. Agilient Technologies Recent Development
 Table 76. Biovia (Dassault Systemes) Company Details
 Table 77. Biovia (Dassault Systemes) Business Overview
 Table 78. Biovia (Dassault Systemes) Pharma ADMET Testing Product
 Table 79. Biovia (Dassault Systemes) Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 80. Biovia (Dassault Systemes) Recent Development
 Table 81. Cyprotex Limited Company Details
 Table 82. Cyprotex Limited Business Overview
 Table 83. Cyprotex Limited Pharma ADMET Testing Product
 Table 84. Cyprotex Limited Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 85. Cyprotex Limited Recent Development
 Table 86. Bio-Rad Laboratories Company Details
 Table 87. Bio-Rad Laboratories Business Overview
 Table 88. Bio-Rad Laboratories Pharma ADMET Testing Product
 Table 89. Bio-Rad Laboratories Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 90. Bio-Rad Laboratories Recent Development
 Table 91. IQVIA Company Details
 Table 92. IQVIA Business Overview
 Table 93. IQVIA Pharma ADMET Testing Product
 Table 94. IQVIA Revenue in Pharma ADMET Testing Business (2020-2025) & (US$ Million)
 Table 95. IQVIA Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Pharma ADMET Testing Picture
 Figure 2. Global Pharma ADMET Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharma ADMET Testing Market Share by Type: 2024 VS 2031
 Figure 4. In Vivo ADMET Testing Features
 Figure 5. In Vitro ADMET Testing Features
 Figure 6. Global Pharma ADMET Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharma ADMET Testing Market Share by Application: 2024 VS 2031
 Figure 8. Systemic Toxicity Testing Case Studies
 Figure 9. Hepatotoxicity Testing Case Studies
 Figure 10. Renal Toxicity Testing Case Studies
 Figure 11. Neurotoxicity Testing Case Studies
 Figure 12. Others Case Studies
 Figure 13. Pharma ADMET Testing Report Years Considered
 Figure 14. Global Pharma ADMET Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Pharma ADMET Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Pharma ADMET Testing Market Share by Region: 2024 VS 2031
 Figure 17. Global Pharma ADMET Testing Market Share by Players in 2024
 Figure 18. Global Top Pharma ADMET Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma ADMET Testing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Pharma ADMET Testing Revenue in 2024
 Figure 20. North America Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Pharma ADMET Testing Market Share by Country (2020-2031)
 Figure 22. United States Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pharma ADMET Testing Market Share by Country (2020-2031)
 Figure 26. Germany Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pharma ADMET Testing Market Share by Region (2020-2031)
 Figure 34. China Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pharma ADMET Testing Market Share by Country (2020-2031)
 Figure 42. Mexico Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pharma ADMET Testing Market Share by Country (2020-2031)
 Figure 46. Turkey Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Pharma ADMET Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. CMIC Holdings Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 50. Charles River Laboratories Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 51. WuXi AppTec Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 52. Promega Corporation Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 53. Merck KGaA Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 54. Agilient Technologies Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 55. Biovia (Dassault Systemes) Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 56. Cyprotex Limited Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 58. IQVIA Revenue Growth Rate in Pharma ADMET Testing Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart